News Feed CDCCDC Statement on Increases in Recent Animal Rabies Activity and Associated Human ExposuresCDC Statement on Increases in Recent Animal Rabies Activity and Associated Human ExposuresTwenty-Five Years After 9/11 — Lessons from the World Trade Center Health ProgramPaper examines 9/11-related health outcomes and lessons learned since the disaster.CDC Launches New Overdose Prevention Data ChannelCDC launches a central data channel to track overdose trends and strengthen prevention nationwide.Outbreak linked to alfalfa sprouts; people sickened with <em>E. coli </em>and <em>Salmonella</em>CDC warns of a multistate Salmonella and E. coli outbreak linked to recalled alfalfa sprout product.CDC Statement on Newly Released Kindergarten Vaccination DataCDC data show kindergarten vaccination rates remain high, with a slight 0.1% decline in coverage.HHS Secretary Kennedy's Remarks Honoring David Rose - August 7, 2026Secretary Kennedy honors Officer David Rose’s courage, sacrifice, and service at the CDC.CDC warns of <em>Salmonella</em> outbreak linked to jalapeñosA CDC food safety alert regarding a multistate outbreak of Salmonella linked to jalapeñosCyclospora outbreak linked to iceberg lettuce expanded to four new states.Cyclospora outbreak linked to iceberg lettuce expanded to four new states.Statement on CDC Public Health Readiness & Response for the FIFA World Cup 2026™The FIFA World Cup 2026™ brought 48 teams and millions of fans to 16 North American cities.Statement on CDC Public Health Readiness & Response for the FIFA World Cup 2026™The FIFA World Cup 2026™ brought 48 teams and millions of fans to 16 North American cities. National Institute of Mental HealthNational NeuroHIV Tissue ConsortiumThe National NeuroHIV Tissue Consortium (NNTC) supports HIV and neurological research by providing high-quality clinical data, biospecimens, and post-mortem tissues. This initiative will sustain and modernize the NNTC as a national resource for studying NeuroHIV, aging-related conditions, antiretroviral therapy, and HIV cure efforts.Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional DrugsThe overarching goal of this concept is to encourage research that aims to better understand the real-world effectiveness of rapid-acting psychotropic interventional drugs (RAPIDs) in heterogenous patient populations and generate the actionable evidence needed by healthcare systems to guide broad clinical implementation.Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes (SSPsyGene) Consortium: Data Resource and Administrative Coordination CenterThis concept aims to continue the Data Resource and Administrative Coordination Center (DRACC) of the Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes (SSPsyGene) Consortium to support ongoing needs for data production and analysis that will continue beyond the current DRACC project end date and to complete consortium studies.AIDS Research Centers (ARCs) and Developmental AIDS Research Centers (D-ARCs) on Mental Health and HIV/AIDSThis concept seeks to support the NIMH AIDS Research Centers program, including D-ARCs and ARCs. The Centers aim to capitalize on their coordinated infrastructure to advance high-impact, interdisciplinary HIV/AIDS research, including at the intersection of HIV/AIDS and mental health, that is relevant to the NIMH DAR mission.BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience ResearchThe Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative plans to continue supporting the development of innovative and transformative neurotechnology tools and approaches that enable the interrogation of cell- and circuit-specific processes in the central nervous system with greater specificity and higher cellular resolution. This concept supports a broad developmental spectrum, from early-stage, high-risk concepts […]NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS)This concept continues the successful NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) program that encourages potentially transformative high-risk, high-reward research from exceptional early stage investigators. The NIMH BRAINS program focuses on research priorities and gap areas identified in the NIMH Strategic Plan for Research.Brain Cell Atlas: From Data to Knowledge BaseThe goal of this concept is to continue supporting an integrated BRAIN® Initiative Cell Atlas Network (BICAN) Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) that will (i) enable the exploration of large-scale brain cell atlas data and knowledge, (ii) inspire research in brain function and disorders, and (iii) ensure research rigor and data reproducibility […]BRAIN Initiative: Data Archives for the BRAIN InitiativeThis is a reissue of the informatics infrastructure program announcement for The Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative data ecosystem. This program has established domain-specific archives that serve as primary repositories for scientific data generated across the BRAIN research portfolio, providing long-term maintenance, standardized curation, compliance with NIH data management and sharing policy, […]Centers for Practice-Based Effectiveness and Services Research with Near-Term ImpactThe goal of this concept is to reissue and extend the NIMH Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers program. The ALACRITY Centers program is intended to support high-impact, practice-based research with near-term potential to significantly advance clinical practice and generate knowledge […]Immunotherapies for HIV Eradication in the CNS CompartmentThe goal of this concept is to generate comprehensive evidence to determine whether immunotherapeutic strategies, including broadly neutralizing antibodies (bNAbs) and antibody-derived constructs, can safely and effectively target HIV persistence within the central nervous system (CNS) compartment while mitigating neuroimmune dysfunction and improving mental health outcomes.
